Expired Tender USA ICB TOT Ref. 78982023

Fentanyl Immunoassay Reagent Test Kits (Fda Tender in USA - 78982023

Tender notice from USA, published on 17 Feb 2023.

Executive Summary

The DEPT OF DEFENSE has issued a Tender notice for the procurement of a Fentanyl Immunoassay Reagent Test Kits (Fda Approved) in the USA. This Tender notice was published on 17 Feb 2023 and is scheduled to close on 03 Mar 2023, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 78982023, while the tender notice number is N6264523R0001 and Register on the platform.

Key facts

Summary
Fentanyl Immunoassay Reagent Test Kits (Fda Approved)
TOT Ref. No.
78982023
Document Ref. No.
N6264523R0001
Country
USA
Notice type
Tender
Competition
ICB
Publication date
17 Feb 2023
Bid deadline
03 Mar 2023
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Description
The Naval Medical Readiness Logistics Command intends to issue a full and open solicitation for the purchase of U.S. Food and Drug Administration (FDA) approved fentanyl immunoassay (IA) drug testing reagent kits for detection in human urine samples in support of the Department of Defense (DoD) Drug Demand Reduction Program (DDRP).
General Requirements. The kits will be used as the initial (screen) IA for the detection of fentanyl in urine when present (and FDA approved) at a concentration equal to or greater than 1 ng/mL. Without modification of the instrumentation, the reagent shall be compatible with the Beckman Coulter AU5800 Series Clinical Chemistry analyzers (purchased from Siemens Healthcare Diagnostics). The Government analyzer will be calibrated at 1 ng/mL using DoD prepared and certified solutions containing fentanyl.
The IA is limited to a two (2) reagent assay procedure. Reagents which require a separate pre-treatment of each specimen prior to testing on the analyzer are not considered acceptable. The reagent shall be compatible with the optimal throughput of the analyzer systems and shall not interfere with the optimum performance of the other immunoassay procedures performed on these instruments. The reagent shall not impose additional maintenance, servicing, or calibration requirements for the optimum performance of the proposed reagent on the analyzer. Immunoassay kits shall have clearance from the FDA in order to meet the requirements of DoDI 1010.16 Rev. (June 15, 2020).
Interested offerors shall be the Original Equipment Manufacturer (OEM) of reagents, authorized dealer, authorized distributor or authorized reseller for the proposed reagents such that OEM parameters, quality controls and services are provided and maintained by the OEM. All storage, shelf life, and expiration dates associated with the reagents shall be in accordance with the OEM terms and conditions. Repackaging or relabeling of an OEM-s reagents prod...
Active Contract Opportunity

Notice ID : N6264523R0001

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEPT OF THE NAVY

Major Command : NAVSUP

Sub Command : NAVSUP OTHER HCA

Sub Command 2 : BUMED

Sub Command 3 : NAVY MEDICINE SUPPORT COMMAND

Office : NAVAL MEDICAL LOGISTICS COMMAND

General Information

Contract Opportunity Type: Presolicitation (Original)

All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Feb 16, 2023 10:46 am EST

Original Response Date: Mar 03, 2023 11:00 am EST

Inactive Policy: Manual

Original Inactive Date: Apr 03, 2023

Initiative: None
Classification

Original Set Aside:

Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: USA

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Fentanyl Immunoassay Reagent Test Kits (Fda Approved) was 03 Mar 2023. Bidding is closed.

This tender has been issued by DEPT OF DEFENSE in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 78982023. The purchaser document reference is N6264523R0001.

Browse other tenders from USA or search by relevant keywords and CPV classification.